Fierce competition among new drug brands for share of India market Sun Pharma Q1 net profit drops 2% YoY, Revenue up 11%; US sales at $471 mn Mankind Pharma IPO to open next week: Check price band, GMP, other details Sun Pharma Q1 profit may be weighed by weak US generic sales and Taro nos Pharma stocks rally on lower price erosion, hopes of US generic mkt uptick India business to boost pharma, after US sales prove to be a mixed bag Mining an opportunity: Firm, transparent laws key to attract investments US Fed hike on expected lines; RBI to take a balanced view: Analysts Dilemma of multilateral finance: Scaling up capital from pvt sector crucial PLI scheme incentive outgo could be less than Rs 40,000 crore by FY25 Statsguru: Top 7 countries account for nearly 70% of vocational students Source link